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The occurrence of spinal cord compression together with quadriplegia due to metastasis from hepato-
cellular carcinoma (HCC) is rare. There is a dilemma over whether to use aggressive treatment when
metastases occur in multiple organs but death is not imminent. Herein, we report the case of a 45-year-
old man who had sudden quadriplegia 22 months after undergoing a right hemihepatectomy for HCC.
Both intrahepatic recurrence and extrahepatic spinal metastasis were found at that time. After an
aggressive surgery for cervical spinal metastasis, he resumed walking and daily activities quickly. His
postoperative ambulation time was at least 4.4 months. The patient could feed himself until the last 2
weeks of life. His survival was 6.8 months, even though he did not receive sorafenib.
Copyright  2013, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Extrahepatic recurrence of hepatocellular carcinoma (HCC) is
infrequent after treatment of the primary tumor [1]. Aggressive
treatment for extrahepatic recurrence may be unnecessary because
it is usually not the cause of death [2]. However, it may lead to
severe disability before death. In this case report, we describe a
patient who experienced quadriplegia from a recurrent tumor in
the cervical spine 22 months after liver resection for HCC.
2. Case report
A 45-year-old man with a history of hepatitis B and C virus co-
infection and liver cirrhosis was diagnosed with a 3.5-cm HCC in
the posterior sector of the liver with right hepatic duct invasion. He
had a right hemihepatectomywithout perioperative complications.
Focal microvascular portal invasion by the tumor was also found
after the surgery. His disease was then under surveillance with
serum alpha-fetoprotein and four-phase liver computed tomogra-
phy (CT) every 3 months.
Twenty-two months after the resection, he experienced sudden
weakness of all four extremities when hewas standing and cookingrgery, Buddhist Tzu Chi Gen-
el.: þ886 3 8561825x6351;
g).
ddhist Compassion Relief Tzu Chiat home. He was weak but still able to take few steps before he was
brought by ambulance to the emergency department. Upon arrival,
he could no longer walk. Physical examination showed quadri-
plegia with preservation of the bilateral deltoid muscle and right
biceps muscle. Sensation in both arms was impaired below the C5
level on the left side and below the C6 level on the right. His liver
functionwas classiﬁed as ChildePugh A. He had thrombocytopenia
(platelets 35,000/mL), similar to that reported before and after liver
resection over the previous 2 years. An emergency magnetic
resonance imaging showed a tumor involving the transverse pro-
cesses, lamina, and spinous processes of the C5, C6, and C7 verte-
brae. C6 spinal cord compressionwas also found (Fig. 1). A dynamic
liver CT revealed a single 3-cm recurrent HCC in segment IV of the
liver. The patient’s serum alpha-fetoprotein level was 60.4 ng/mL.
The patient received high dose of corticosteroids in the emer-
gency department. Palliative radiotherapy alone was initially
considered. However, severe pain in his neck and shoulders became
worse and then voluntary ﬂexion of his right elbowwas completely
lost within 3 days. A total laminectomy of the C5, C6, and C7
vertebrae, and excision of the spinal bone tumor was done. The
pathologic diagnosis was metastatic HCC and immunohistochem-
ical staining for glypican-3 was positive. The surgical margin was
not free but contained cancer cells.
The patient resumed walking within 10 days after the surgery.
The power of themuscles innervated by the C7 toT1 nerve roots did
not completely recover, butmotor function in both upper limbs was
good enough to perform daily activities. He was able to urinate and
defecate independently. The intrahepatic recurrencewas treated byFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. T2 MRI showing C6 spinal cord compression from a metastatic bone tumor.
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also tolerated subsequent radiotherapy of 40 Gy in 20 fractions to
his spine. However, the patient could not afford sorafenib.
The pain in the posterior aspect of the patient’s neck and
bilateral shoulders was mild and he handled daily life indepen-
dently in the ﬁrst 3 months after treatment. Transarterial chemo-
embolization was repeated for the same intrahepatic tumor.
However, progressive numbness and greater pain in the bilateral
shoulders to forearms began 4.4 months after spinal decompres-
sion. Magnetic resonance imaging showed focal recurrence of HCC
(Fig. 2). Multiple asymptomatic subcentimeter lung metastases
were also revealed. Intrahepatic disease appeared stable on a dy-
namic CT. Comfort care without invasive treatments was chosen atFig. 2. T2 MRI showing the cervical spinal cord surrounded by focal recurrence in the
epidural soft tissue behind and the body of C6 vertebral bone in front.that time. The patient died in a hospice at the hospital 6.8 months
after the spinal surgery. He had lived outside the hospital for a total
of 84 days postoperatively. In the patient’s last 4 weeks of life,
standing and walking became very difﬁcult because of whole-body
pain and weakness in the bilateral lower extremities. Muscle power
and coordination of both hands and ﬁngers worsened. However,
the patient still fed himself until the last 2 weeks of his life. Serum
bilirubin and albumin levels were normal and there was no jaun-
dice, symptomatic ascites, or gastrointestinal bleeding before
death. Signs of respiratory distress were not obvious until the last
moments of life. Although neurogenic respiratory failure due to
tumor compression or invasion into spinal cord was suspected, the
direct cause of death was not conﬁrmed by autopsy reports.
3. Discussion
The incidence of extrahepatic bonemetastasis of HCCwas low in
an HCC pandemic area [1]. Routine examination for bone metas-
tasis was not included in surveillance of patients with HCC. For
patients with concurrent intrahepatic HCC and extrahepatic me-
tastases, and alsowith good performance status and preserved liver
function, sorafenib is the recommended treatment worldwide [3e
5]. Survival of these patients may also beneﬁt from transarterial
chemoembolization for liver tumors [6]. In highly selected patients,
surgical resection of HCC lung metastases may prolong survival
[7,8]. However, surgical resection versus nonsurgical treatment has
not been well studied for HCC vertebral metastases. With meta-
static spinal cord compression and quadriplegia, as in our patient,
the situation can become an oncologic emergency and sorafenib
administration alone would not be enough. Aggressive, rapid
treatment is required to improve the patient’s quality of life. A
combination of high-dose dexamethasone and radiotherapy is the
established ﬁrst-line therapy for metastatic spinal cord compres-
sion [9]. However, HCC has an unfavorable histology for radio-
therapy [10]. When radiation dose escalation is not tolerated by
patients, surgical decompression can be used for salvage treatment
[11]. Such salvage surgery should be done early, because post-
operative ambulation time was much longer in patients who were
not nonambulatory yet before spinal surgery [12]. Our patient
recovered soon after the surgery. His walking ability was Nurick
Grade 3 or better for at least 4.4 months [13]. His performance was
good enough for activities with his family in the last several months
of his life. This performance was very important for him to prepare
for the end of his life as he could take videos of himself as last gifts
to his child. This experience has encouraged us to consider surgical
treatment for similar patients in the future.
The purpose of surgery and radiation for our patient was pres-
ervation of neurologic function but not survival. Although sorafenib
may prolong his survival, he cannot afford it. In the Asia-Paciﬁc trial
of sorafenib, the median overall survival was 4.2 months [95%
conﬁdence interval (CI): 3.75e5.46] in the placebo group and 6.5
months (95% CI: 5.56e7.56) in the sorafenib group [14]. Although
our patient did not have sorafenib, his survival time after spinal
surgery was 6.83 months. His outcome was not inferior to that of
most patients with advanced HCC who did not receive sorafenib,
and was comparable with patients who did receive sorafenib. The
direct cause of death of this patient was not the intrahepatic
recurrent tumor or liver failure. This was an unusual case because
approximately 95% of patients with HCC extrahepatic metastasis
die of primary liver disease or liver failure rather than extrahepatic
disease [2]. It is possible that aggressive treatment of extrahepatic
tumors can prolong survival if such extrahepatic tumor is expected
to be the direct cause of death in the future. However, prediction of
direct cause of death is still very difﬁcult when concurrent intra-
hepatic and extrahepatic recurrences are found.
Y.-C. Yang, S.-T. Tsai / Tzu Chi Medical Journal 26 (2014) 94e9696In conclusion, when patients without liver failure or imminent
death develop quadriplegia, spinal surgery to restore neurologic
function is worthwhile. It can improve quality of life, even if it does
not really prolong life.
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